Seller record · Research vendor

Evolve Peptides

By Peptide Alliance, Editorial publisherRecorded September 2026 · Standard v1.1 · How checks are performed

Fails 3 of 8 criteria. S1, prescriber requirement: No clinician reviews an order. An age gate asking the buyer to confirm twenty one years is the only condition of entry. 2 more criteria also fail; see the table below.

At a glance

Evolve PeptidesResearch vendor

5/8criteria passed

Price: Printed on its own pages before sign-up
Sells: research peptides including BPC-157 and semaglutide, peptide blends, and 2 more
FDA letters: None on file

Visit Evolve Peptides See all eight dispositions

Research vendor. Passes 5 of 8 criteria. Recorded against Standard v1.1.

A research peptide seller in Casper, Wyoming, advertising four rounds of third-party testing on every batch. Its retatrutide pages show reports from three laboratories, while its certificate page remains a lookup that needs a lot number.

Operating entity No legal entity name is printed in the footer, the contact page, the terms and conditions or the privacy policy.

Dispositions

Code	Criterion	Disposition	Where it appears
S1	Prescriber requirement	FAIL	Evolve Peptides' terms and conditions
S2	Prescription gating	FAIL	Evolve Peptides' checkout
S3	Pharmacy identification	FAIL	Evolve Peptides' COA lookup page
S4	Compounding disclosure	PASS	Evolve Peptides' COA lookup page
S5	Analytical documentation	PASS	Evolve Peptides' posted image
S6	Business address	PASS	Evolve Peptides' contact page
S7	Price disclosure	PASS	Evolve Peptides' peptides category page
S8	Enforcement status	PASS	FDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1FAILNo clinician reviews an order. An age gate asking the buyer to confirm twenty one years is the only condition of entry.Source: Evolve Peptides' terms and conditions.

S2FAILA checkout collects an email address and a shipping address with no eligibility question.Source: Evolve Peptides' checkout.

S3FAILNo pharmacy is named. A site-wide notice states that the seller is not a compounding pharmacy under section 503A.Source: Evolve Peptides' COA lookup page.

S4PASSThe seller offers no compounded drug, and a site-wide notice states that products are supplied strictly for research and not for human consumption.Source: Evolve Peptides' COA lookup page.

S5PASSThe retatrutide product pages show certificate images, among them an MZ Biolabs report of 99.97 percent purity on lot 3468012957, reachable with no login.Source: Evolve Peptides' posted image.

S6PASSThe contact page prints a street address on East 2nd Street in Casper, Wyoming, and the certificate page repeats it.Source: Evolve Peptides' contact page.

S7PASSThe peptide category prints prices with no account required, among them 15.90 dollars, 34.90 dollars and 149.90 dollars.Source: Evolve Peptides' peptides category page.

S8PASSNo FDA warning letter names the storefront, and no action has halted the business.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: research peptides including BPC-157 and semaglutide, peptide blends, reconstitution supplies, retatrutide.

Other sellers of the same products

Who sells semaglutide Who sells BPC-157 Who sells retatrutide

Visit Evolve Peptides

535 sellers pass S1, prescriber requirement

See all 535 on the S1 criterion page — 527 more than shown here.

This seller fails criteria a medical service must meet. The records above belong to sellers that pass S1; some are partner links, disclosed on their records.

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.